Introduction {#s1}
============

Axial mesendoderm is a transient midgestation tissue located at the midline of 7.0--8.5 day post coitus (dpc) mouse embryos which is critical for patterning adjacent tissues, including neural ectoderm and paraxial mesoderm ([@b19]; [@b60]; [@b28]). Axial mesendoderm is derived from anterior regions of primitive streak during gastrulation including the node organizer, is initially contiguous with endodermal epithelium, and is anatomically distinct due to its direct apposition with overlying neural groove ectoderm ([@b20]; [@b5]; [@b48]; [@b24]; [@b29]; [@b63]; [@b28]).

Axial mesendoderm is comprised of notochordal plate and prechordal plate, the most anterior mesendoderm ([@b48]; [@b63]). Notochordal plate will give rise to notochord and contribute to dorsal foregut endoderm, and prechordal plate will contribute to ventral foregut endoderm, oral endoderm, and ventral cranial mesoderm ([@b9]). Tissue ablation studies have demonstrated that prechordal plate reinforces forebrain induction and regulates other aspects of anterior development ([@b45]; [@b7]). Additionally, defects in anterior embryonic patterning have been associated with disruption of prechordal plate markers ([@b2]; [@b59]; [@b16]; [@b4]; [@b41]; [@b39]; [@b57]). Attribution of tissue specific roles of genes expressed in prechordal plate in notochord development, however, has been limited by the lack of a prechordal plate-specific Cre line that is not active in other axial mesendodermal regions.

The forkhead transcription factor *Foxa2* is expressed in critical signaling centers during development, including node, notochord, and prechordal plate, and is also expressed in both extraembryonic and embryonic endoderm. Global knockout of *Foxa2* has revealed critical roles in embryonic patterning and a requirement for endoderm formation ([@b2]; [@b59]; [@b12]). Conditional *Foxa2* deletion utilizing an endodermal-specific *Foxa3-Cre* line, however, did not result in defects in gut formation, perhaps owing to persistence of Foxa2 protein in mutant foregut endoderm at 9.5 dpc ([@b27]). Thus far, roles for *Foxa2* in prechordal plate, or in early ventral endoderm, have not been investigated.

Dorsal and ventral foregut endoderm have unique embryonic origins, with distinct timing of emergence from the primitive streak and divergent migratory pathways that converge to comprise the entire foregut endoderm ([@b51]; [@b50]). Gut tube formation begins in the anterior embryo at early to late head fold stages (EHF-LHF, ∼8.0--8.25 dpc) when an initially flat sheet of endodermal epithelium is transformed into a pocket structure. Ventral midline of the foregut is a discrete population derived from prechordal plate ([@b25]; [@b17]; [@b3]). The foregut pocket remains open anterior to the site of fusion, termed the anterior intestinal portal.

To investigate tissue-specific roles for *Foxa2* in prechordal plate and ventral foregut endoderm, we have ablated *Foxa2* utilizing *Isl1-Cre* ([@b49]; [@b64]). Use of *Isl1-Cre* has allowed us to genetically isolate prechordal plate from posterior axial mesendoderm to address patterning by axial mesendoderm, and our results reveal a requirement for prechordal plate in development of notochord and dorsal foregut endoderm, both derivatives of notochordal plate. Our data also demonstrate a cell autonomous role for Foxa2 in ventral foregut endoderm for endoderm specification and foregut morphogenesis.

Results {#s2}
=======

Isl1-Cre lineages overlap with Foxa2 in prechordal plate, ventral foregut and yolk sac endoderm {#s2a}
-----------------------------------------------------------------------------------------------

To investigate overlap between *Isl1-Cre* and Foxa2 expression, *Isl1-Cre*; *Rosa^+/26R-lacZ^* embryos were analyzed beginning at early headfold (EHF) stages. Whole mount X-gal staining of EHF Isl1-Cre; Rosa+/26R embryos demonstrated low levels of β-galactosidase staining in the allantois. At these stages, β-galactosidase-positive domains were not detected in the embryo proper or in yolk sac endoderm anterior to the emergent head folds (supplementary material Fig. S1). At 3--5 som, β-galactosidase staining was not detected in extraembryonic tissues outside of the allantois in *Isl1-Cre*; *Rosa^+/26R-lacZ^* embryos (supplementary material Fig. S1). *Isl1-Cre* activity is first evident in embryonic endoderm at 2--3 som ([@b40]). At this stage, histological section analyses demonstrated that *Isl1-Cre*-derived cells were present in prospective ventral foregut caudal to the foregut pocket, and in ventral foregut endoderm extending to the rostral pocket tip ([Fig. 1A--F](#f01){ref-type="fig"}). Rostralmost *Isl1-Cre* labeled cells included prechordal plate as indicated by direct apposition to overlying neural ectoderm, consistent with previous studies demonstrating *Isl1* expression in prechordal plate in chick embryos ([@b65]). *Isl1-Cre*-derived cells were also evident in head and heart mesoderm ([@b53]), and in yolk sac endoderm underlying the heart.

![Isl1-Cre lineages and Foxa2 expression.\
Section analysis of Isl1-Cre; R26R-lacZ embryos, immunostaining for b-galactosidase **(A--C)** or by X-gal staining **(D--F)**, demonstrated Isl1-Cre labeling in prechordal plate **(A, D)**, foregut endoderm **(B, E, D, F)**, and yolk sac endoderm underlying the heart **(E)**. Section immunostaining with antibodies to Foxa2 in control embryos **(G--I)** demonstrated overlapping expression of Foxa2 and Isl1-Cre lineages in prechordal plate **(G)**, ventral foregut endoderm **(H, I,)**, and yolk sac endoderm underlying the heart **(H)**. Isl1-Cre lineages were not observed in other sites of Foxa2 expression, including ectoderm of the neural groove (future floorplate) **(G, H)**, notochord **(I)**, or dorsal endoderm **(H)**. Section immunostaining with antibodies to Foxa2 in Foxa2loxP/loxP; Isl1-Cre stage-matched littermate mutant embryos demonstrated reduction of Foxa2 expression in prechordal plate **(J)**, ventral foregut **(K, L)**, and yolk sac endoderm **(K)** (white arrows). Foxa2 expression was also reduced in the midline of the neural groove **(J, K)** (white arrowhead).](bio-01-03-173-f01){#f01}

Examination of Foxa2 expression by immunohistochemistry demonstrated that Foxa2 and *Isl1-Cre* overlapped in prechordal plate, foregut endoderm, and yolk sac endoderm underlying cardiogenic mesoderm ([Fig. 1G--I](#f01){ref-type="fig"}). As expected, ablation of Foxa2 with Isl1-Cre resulted in reduction of Foxa2 expressing cells in overlapping regions including prechordal plate ([Fig. 1J](#f01){ref-type="fig"}), ventral foregut endoderm ([Fig. 1K,L](#f01){ref-type="fig"}), and yolk sac endoderm underlying the heart ([Fig. 1J](#f01){ref-type="fig"}). Foxa2 expression was also diminished in the midline of the neural groove ([Fig. 1J,K](#f01){ref-type="fig"}), indicating a non-cell autonomous loss of Foxa2 in this expression domain.

Further analysis confirmed that *Isl1-Cre* lineages did not overlap with Foxa2 expression in node, notochordal plate or its derivatives, including dorsal foregut endoderm and notochord, or floor plate of the neural tube ([Fig. 2](#f02){ref-type="fig"}).

![Isl1-Cre lineages do not include node or notochord, 8.25--8.5 dpc.\
**(A--C)** X-gal-stained Isl1-Cre; Rosa+/26R embryo, 3 som, anterior **(A)**, right **(B)**, posterior **(C)** views. Isl1 lineages did not include node (white arrowheads in B, C). **(D--F)** X-gal-stained Isl1-Cre; Rosa+/26R embryo, 7 som, anterior-left **(D)**, right **(E)**, posterior **(F)** views. Isl1 lineages did not include notochordal plate (black arrowhead in F). Black lines in E indicate planes of section for G--I. **(G)** Section through foregut and ventricle of embryo in D. Black box indicates posterior embryo region shown at high magnification in H. **(H--I)** Sections through posterior embryo regions with **(H)** notochordal plate (ntp) or **(I)** hindgut pocket (hgp). Black arrowhead in I marks site of continued gastrulation. Bar in: A is 0.2 mm for A--C; D is 0.2 mm for D--F; G is 0.1 mm; H is 0.05 mm for H--I. aip, anterior intestinal portal; al, allantois; nf, neural fold; ng, neural groove; v, ventricle.](bio-01-03-173-f02){#f02}

*Foxa2* is required in *Isl1* lineages for forebrain and anterior embryonic patterning, and for heart and foregut morphogenesis {#s2b}
-------------------------------------------------------------------------------------------------------------------------------

Previous studies have demonstrated a role for Foxa2 in axial mesendoderm for forebrain and anterior embryonic patterning. However, owing to lack of suitable Cre drivers, it has been difficult to dissect the requirement for Foxa2 in prechordal plate from its requirement in other axial patterning tissues. Our analysis of *Isl1-Cre* lineages demonstrated that *Isl1-Cre* would allow us to selectively examine the cell autonomous requirement for Foxa2 in prechordal plate in forebrain and anterior patterning apart from its requirement in notochord or floorplate. To investigate the potential role of Foxa2 in tissues which overlapped with those labeled by *Isl1-Cre,* including prechordal plate and foregut endoderm, we utilized *Isl1-Cre* to generate tissue-specific deletion of *Foxa2*.

Heterozygous *Foxa2^+/loxP^*; *Isl1-Cre* mice were viable, fertile, and displayed no obvious abnormalities. Most homozygous *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants were dead by 12.5--13.5 dpc (*n* = 9/11, supplementary material Table S1), were morphologically distinct at 8.5 dpc (*n* = 31/41), and displayed a range of phenotypes (supplementary material Table S2; [Fig. 3](#f03){ref-type="fig"}). Mutant embryos displayed defects in anterior patterning, including abnormal head fold morphology, and abnormal neural groove ([Fig. 3C,E](#f03){ref-type="fig"}). Laterality defects were evidenced by reversed or no cardiac looping in some mutants. Lack of foregut closure and cardia bifida were also seen ([Fig. 3E, F](#f03){ref-type="fig"}; supplementary material Fig. S2). Previous studies have demonstrated that defects in endoderm which result in lack of foregut closure can result in cardia bifida ([@b33]; [@b1]). Holoproencephaly, a disorder resulting from deficient ventral forebrain patterning ([@b37]), was also observed (supplementary material Fig. S1).

![Anterior patterning and cardiac defects in Foxa2loxP/loxP; Isl1-Cre embryos, 8.5 dpc.\
**(A)** 8.5 dpc Foxa2loxP/loxP embryo, 4 somite pairs (4 som), anterior brightfield view. **(B)** Close-up view of embryo shown in A. **(C)** Close-up view of Foxa2loxP/loxP; Isl1-Cre embryo, 4 som. Black arrows in B--C mark rostral neural groove, white arrows anterior intestinal portal. Black arrowhead in C shows abnormal neural groove. **(D--F)** 8.5 dpc Foxa2loxP/loxP **(D)** and Foxa2loxP/loxP; Isl1-Cre **(E--F)** embryos, 8 som, anterior views. Mutant in E lacked neural groove in rostral and trunk regions (black arrows). Abnormal cardiac development is evident in mutant embryos. White arrowheads in E--F mark yolk sac, amnion attachment above or at level of cardiac anlagen (red arrows). Bar in: A is 0.2 mm; B is 0.1 mm for B--C; D is 0.2 mm for D--F. am, amnion; ht, heart; nf, neural fold; ng, neural groove; v, ventricle; ys, yolk sac.](bio-01-03-173-f03){#f03}

To determine whether ectopic *Isl1-Cre* activity contributed to the range of phenotypes observed at 9.5--10.5 dpc, *Foxa2^loxP/loxP^*; *Isl1-Cre* embryos were generated on a *Rosa^26R-lacZ^* lineage reporter background ([@b47]; [@b64]). Results showed specific *Isl1-Cre* expression in mutants displaying the full spectrum of abnormalities (supplementary material Fig. S2C--E\').

To investigate whether defects in anterior patterning were separable from defects in foregut closure and cardia bifida, mutants were analyzed for mutual exclusivity of these two broad classes of phenotypes (supplementary material Table S3). Results of this analysis demonstrated that these abnormalities in foregut and cardiac morphogenesis could occur in the absence of defects in anterior patterning, suggesting distinct spatial and/or temporal requirements for Foxa2 for these two aspects of the *Foxa2^loxP/loxP^*; *Isl1-Cre* mutant phenotype.

Abnormal development of axial mesendoderm in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants is associated with increased apoptosis {#s2c}
--------------------------------------------------------------------------------------------------------------------------

Specific defects in anterior patterning and laterality defects as evidenced by reversed or no cardiac looping in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants suggested perturbations in axial mesendoderm. In situ hybridization was used to assay axial mesendoderm marker gene expression in 8.0--8.5 dpc *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants. At these stages, *Goosecoid* (*Gsc*), a homeobox transcription factor, is a marker of prechordal plate ([@b16]). *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants exhibited markedly reduced *Gsc* expression at E8.0 (6 som) ([Fig. 4B](#f04){ref-type="fig"}). *Fibroblast growth factor 8* (*Fgf8*) marks anterior neural ridge, a signaling center that interacts with prechordal plate to regulate anterior forebrain patterning and expansion ([@b10]; [@b45]). *Fgf8* is also expressed at the midbrain-hindbrain boundary ([Fig. 4C](#f04){ref-type="fig"}). Expression of *Fgf8* in anterior neural ridge was reduced in mutant embryos, while its expression at the midbrain-hindbrain junction was unaffected ([Fig. 4D](#f04){ref-type="fig"}).

![Axial mesendoderm marker gene expression in Foxa2loxP/loxP; Isl1-Cre embryos, 8.0--8.5 dpc.\
**(A--B)** In situ hybridization (ISH) to detect Gsc in Foxa2+/loxP **(A)** and Foxa2loxP/loxP; Isl1-Cre **(B)** embryos, 6 som, anterior views. **(C--D)** ISH to detect Fgf8 in Foxa2loxP/loxP **(C)** and Foxa2loxP/loxP; Isl1-Cre **(D)** embryos, 8 som, anterior-right views. Control embryos expressed Fgf8 in anterior neural ridge (black arrow) and neural ectoderm at midbrain-hindbrain boundary (black arrowheads). **(E--F)** ISH to detect Shh in Foxa2+/loxP **(E)** and Foxa2loxP/loxP; Isl1-Cre **(F)** embryos, 5 som, anterior views. **(G--J)** Transverse sections after ISH to detect Brachyury in Foxa2loxP/loxP **(G, I)** and Foxa2loxP/loxP; Isl1-Cre **(H, J)** embryos, 7 som. **(G--H)** Sections through foregut with midline heart. **(I--J)** Sections posterior to the anterior intestinal portal. Bar in: A is 0.2 mm for A--F; G is 0.1 mm for G--J.](bio-01-03-173-f04){#f04}

*Sonic hedgehog* (*Shh*) is a secreted factor expressed throughout axial mesendoderm which is required for survival of prechordal plate cells and dorsal ventral patterning of the neural tube ([@b14]; [@b8]; [@b11]; [@b3]). At E8.0, *Shh* mRNA expression was absent in anterior regions of mutant embryos. Trunk regions exhibited patchy expression of *Shh* which did not extend to posterior regions as observed in somite-matched controls ([Fig. 4E--F](#f04){ref-type="fig"}). Immunostaining confirmed that Shh protein was also absent from anterior regions of *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants, and was abnormally positioned to the left of the midline in more posterior regions (supplementary material Fig. S3).

*Brachyury* is a T-box transcription factor expressed in notochord at 8.5 dpc ([Fig. 4G,I](#f04){ref-type="fig"}). Notochord cells marked by *Brachyury* expression were disorganized and abnormally positioned to the left of the midline in mutant embryos (7 som) ([Fig. 4H](#f04){ref-type="fig"}), while other more anterior and posterior regions showed complete absence of *Brachyury* expression ([Fig. 4J](#f04){ref-type="fig"}).

TUNEL and immunohistochemistry to detect Brachyury were used to investigate notochord survival in 8.5 dpc *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants. In control littermates, notochord cells were detected in a continuous anterior-posterior domain, and were not associated with apoptosis ([Fig. 5A--D](#f05){ref-type="fig"}). Again, Brachyury was absent from the anterior region of mutant embryos ([Fig. 5E--F](#f05){ref-type="fig"}). The most anterior limit of Brachyury expression was detected posterior to the anterior intestinal portal and positive cells were again observed to be somewhat disorganized and abnormally positioned leftward of the neural groove ([Fig. 5H](#f05){ref-type="fig"}). In mutant embryos, apoptosis was observed in midline regions rostral to Brachyury expression ([Fig. 5](#f05){ref-type="fig"}).

![Notochord and apoptosis in Foxa2loxP/loxP; Isl1-Cre embryos, 8.5 dpc.\
TUNEL staining and immunohistochemistry to detect Brachyury on transverse section series of Foxa2+/loxP; Isl1-Cre **(A--D)** and Foxa2loxP/loxP; Isl1-Cre **(E--H)** embryos, 7 som. Sections are anterior to posterior (A to D for control, E to H for mutant). White arrowheads **(A--D, H)** indicate notochord as marked by Brachyury expression.](bio-01-03-173-f05){#f05}

Notochord abnormalities do not correlate with loss of Foxa2 in ventral endoderm {#s2d}
-------------------------------------------------------------------------------

Our data demonstrated that loss of Foxa2 in regions which overlap with *Isl1-cre* lineages resulted in defects in notochord formation and morphogenesis. *Isl1-cre* lineages overlap with Foxa2 in both prechordal plate and ventral foregut endoderm. In individual mutant embryos, we observed loss of notochord markers even when Foxa2 was present in ventral foregut endoderm, suggesting that loss of notochord markers is not consequent to loss of Foxa2 in ventral foregut endoderm ([Fig. 6A--H](#f06){ref-type="fig"}). Notochord defects were scored by absence of a morphologically recognizable notochord structure and lack of characteristic floor plate morphology, lack of Foxa2 protein expression in neural plate midline, and lack of detectable Brachyury or Shh protein expression. Hlxb9 is expressed in notochord and dorsal endoderm, and was also found to be greatly reduced in both tissues in these mutants ([Fig. 6F](#f06){ref-type="fig"}). In other mutants, expression of axial tissue and dorsal foregut endoderm markers was maintained despite loss of Foxa2 from ventral foregut endoderm ([Fig. 6I--J](#f06){ref-type="fig"}). Markers utilized were Foxa2 in presumptive floor plate, Brachyury in notochordal plate, and Hlxb9 in notochord and dorsal foregut.

![Lack of correlation between notochord marker expression in Foxa2loxP/loxP; Isl1-Cre embryos and Foxa2 ablation in ventral foregut endoderm, 8.5 dpc.\
Immunohistochemistry (IHC) to detect Foxa2 **(A, E, I)**, Hlxb9 **(B, F, J)**, Brachyury **(C, G, K)** and Shh **(D, H)** on transverse sections of Foxa2loxP/loxP **(A--D)** and Foxa2loxP/loxP; Isl1-Cre **(E--H, I--K)** embryos, 8--9 somite pairs (som). White arrowheads **(C, D, K)** indicate notochord as marked by Brachyury or Shh expression. The mutant in I--K maintained expression of axial tissue markers despite loss of Foxa2 from ventral foregut endoderm (white arrows in I).](bio-01-03-173-f06){#f06}

Aberrant ventral foregut morphogenesis in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants is associated with downregulation of epithelial and endodermal markers, decreased proliferation, and increased apoptosis in foregut endoderm {#s2e}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ventral endoderm forms a highly organized epithelium with tight junctions. Recent studies have demonstrated a role for Foxa2 in maintenance of epithelial integrity in the early embryo ([@b6]). Previous studies in mouse liver tissue have shown that Foxa2 directly binds to regions within the *tight junction protein 1* (*Tjp1)* locus encoding ZO-1 suggesting ZO-1 is a direct downstream target of Foxa2 ([@b58]). Therefore, we performed immunostaining for ZO-1 and ZO-2 in *Foxa2loxP/loxP*; *Isl1-Cre* embryos at 4--5 som. Apico-lateral localization of ZO-1 and ZO-2 was observed in epithelium of both formed and prospective foregut endoderm of control embryos ([Fig. 7A](#f07){ref-type="fig"}). *Foxa2loxP/loxP*; *Isl1-Cre* endodermal segments composed of Foxa2- negative cells exhibited reduced to absent expression of both ZO-1 and ZO-2 ([Fig. 7B](#f07){ref-type="fig"}). Isolated groups of Foxa2-expressing cells embedded in Foxa2-negative epithelium displayed persistent expression of ZO-1 (data not shown) and ZO-2 ([Fig. 7C,D](#f07){ref-type="fig"}), demonstrating that the observed effect is specific and cell autonomous.

![Decreased expression of proteins critical to ventral foregut morphogenesis in Foxa2loxP/loxP; Isl1-Cre embryos embryos.\
**(A--D)** Anti-Foxa2 and anti-ZO-1 **(A--B)** or anti-ZO-2 **(C--D)** coimmunohistochemistry (IHC) on Foxa2+/loxP **(A, C)** and Foxa2loxP/loxP; Isl1-Cre **(B, D)** embryos with 4--5 somite pairs (som). **(A--B)** Sections posterior to the anterior intestinal portal. **(C--D)** Sections through the foregut. White arrow in D marks a cluster of cells retaining expression of both Foxa2 and ZO-2. **(E--F)** Sections of anti-SOX17, anti-E-cadherin co-IHC near the anterior intestinal portal of Foxa2+/loxP **(E)** and Foxa2loxP/loxP; Isl1-Cre **(F)** embryos with 5 som. Segments of ventral foregut endoderm lacking Sox17 expression were observed in the mutant (white arrowheads). **(G--H)** Anti-Gata4, anti-E-cadherin (E-cad) co- IHC on sections of Foxa2loxP/loxP **(G)** and Foxa2loxP/loxP; Isl1-Cre **(H)** embryos with 5 somite pairs (som). Sections are posterior to the anterior intestinal portal. E-cadherin localizes to epithelial membranes and marks foregut endoderm. **(I)** Anti-Foxa2, anti-E-cadherin co-IHC on a section adjacent to that shown in B.](bio-01-03-173-f07){#f07}

To investigate whether Foxa2 is required to maintain endodermal identity in foregut, immunohistochemistry was used to investigate expression of the transcription factor Sox17, a marker of endodermal identity ([@b21]). Control embryos with 4--5 som displayed several sites of specific positive signal for Sox17 in addition to foregut endoderm, including endocardium and cells throughout the mesenchyme that are often in close association with the foregut ([Fig. 7E](#f07){ref-type="fig"}). Low levels of Sox17 expression reported in vascular and endocardial endothelium could account for some of the positive signal detected outside of the foregut ([@b43]). Co-immunohistochemistry with an anti-E-cadherin antibody was performed to positively identify Sox17-expressing foregut endoderm. *Foxa2loxP/loxP*; *Isl1-Cre* embryos with 5 som displayed patches of E-cadherin-positive endoderm lacking Sox17 expression in the ventral foregut ([Fig. 7E](#f07){ref-type="fig"}) that correlated with regions of reduced-to-absent Foxa2 expression (data not shown). Sox17 expression was unchanged in dorsal foregut of mutant embryos.

Shortened foregut and defective midline cardiac fusion in *Foxa2loxP/loxP*; *Isl1-Cre* mutants indicated a role for *Foxa2* during ventral morphogenesis. Embryos homozygous null for the transcription factor *Gata4* similarly exhibit cardia bifida and lack of foregut closure ([@b26]). Additionally, *Foxa2* directly binds to the *Gata4* locus in adult mouse liver, supporting a role for *Foxa2* as a direct upstream regulator of *Gata4* expression ([@b58]). Gata4 protein was detected in endoderm associated with cardiogenic mesoderm near the anterior intestinal portal of control embryos with 4--5 som ([Fig. 7G](#f07){ref-type="fig"}). Endodermal Gata4 expression was greatly reduced in this region of *Foxa2loxP/loxP*; *Isl1-Cre* mutants and correlated with areas of reduced-to-absent Foxa2 protein levels ([Fig. 7H,I](#f07){ref-type="fig"}).

To quantify shortened foregut pockets in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants, foregut pocket length was measured in 8.5 dpc control and mutant embryos at 5 som. Analysis revealed that *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants exhibited significantly shorter rostral-caudal foregut pocket length when compared to somite-matched controls (supplementary material Fig. S4).

To investigate potential causes for shortened foregut pocket length in mutants, foregut endoderm cell proliferation and apoptosis were compared between 8.5 dpc *Foxa2^loxP/loxP^*; *Isl1-Cre* and control embryos (4--6 som) ([Fig. 8](#f08){ref-type="fig"}). To quantify proliferation, cells positive for the mitotic marker phosphohistone H3 (P-H3) were counted and calculated as a percentage of total foregut pocket cell number. Total foregut pocket P-H3 levels were significantly reduced in mutant versus control populations and correlated with significantly reduced proliferation in ventral foregut ([Fig. 8 A--C](#f08){ref-type="fig"}). TUNEL assays were performed to assay apoptosis. TUNEL-positive cells were counted and calculated as a percentage of total foregut pocket cell number. Total foregut pocket TUNEL levels were significantly increased in mutant versus control populations and correlated with significantly increased levels in dorsal and ventral foregut ([Fig. 8 D--F](#f08){ref-type="fig"}).

![Proliferation and Apoptosis in Foregut of Foxa2loxP/loxP; Isl1-Cre Mutants.\
**(A, B)** To assay proliferation, antibody to phosphorylated histone 3 (P-H3) was utilized on sections from somite matched littermate control or Foxa2loxP/loxP; Isl1-Cre mutants. **(C)** Quantitative analysis is shown. **(D,E)** Apoptosis was assessed by Tunel staining of control or mutant sections. **(F)** Quantitative analysis is shown, demonstrating selective decrease in proliferation in ventral foregut, and increased apoptosis in both dorsal and ventral foregut. \**P*\<0.01.](bio-01-03-173-f08){#f08}

Discussion {#s3}
==========

Embryological approaches in mouse have shown that prechordal plate is required to support identity and growth in overlying forebrain ectoderm ([@b45]; [@b7]) with previous work suggesting involvement of *Foxa2* in these roles. Anterior embryo patterning phenotypes in mouse, such as holoprosencephaly, are correlated with disrupted expression of prechordal plate marker genes including *Foxa2* ([@b2]; [@b59]; [@b16]; [@b4]; [@b41]; [@b39]; [@b57]). A role for *Foxa2* in prechordal plate during anterior embryo morphogenesis has also been supported by the phenotype of double *Gsc* null-*Foxa2* heterozygous mutants which exhibited abnormal forebrain morphology similar to that observed in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants ([@b16]). Until now, genetic approaches to directly investigate patterning roles of prechordal plate, and roles for *Foxa2* in this tissue, have been encumbered by lack of a prechordal plate-specific Cre line that is exclusive of other axial mesendoderm components such as notochord. Isl1Cre ablates in prechordal plate and in ventral foregut endoderm, but not other axial mesendoderm. *Isl1-Cre*-mediated ablation of *Foxa2* results in anterior embryo patterning phenotypes previously seen consequent to perturbations of axial mesendoderm. These anterior patterning phenotypes were observed in mutant embryos which had preserved expression of Foxa2 in ventral foregut endoderm. Conversely, notochord and dorsal foregut endoderm markers were present in embryos in which Foxa2 was absent from ventral foregut endoderm. Taken together, our data suggest a primary role for Foxa2 in prechordal plate for notochord development and/or maintenance. Ideally, it would be preferable to complement our studies with a Cre recombinase which would be selectively active in ventral foregut endoderm, and not in prechordal plate. However, our attempts to utilize Nkx2.5cre to this effect were unsuccessful, owing to perdurance of Foxa2 protein in ventral foregut endoderm, despite successful recombination as indicated by lineage indicators.

Previous studies of dorsal foregut endoderm have focused on elucidating pathways that stimulate budding of organ primordia, such as pancreas ([@b66]). Little is known as to factors which pattern dorsal foregut endoderm at earlier stages. *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants exhibit reduced expression of the dorsal foregut marker Hlxb9. Lack of *Isl1-Cre* activity in dorsal foregut indicates a non-autonomous requirement for *Foxa2* in patterning of dorsal foregut endoderm. We observed a lack of correlation between loss of Foxa2 in ventral foregut endoderm and downregulation of Hlxb9, suggesting a role for prechordal plate in maintenance of dorsal foregut endoderm identity. It is interesting to speculate that mutual signaling between contiguous dorsal endoderm and notochord may be required for specification or maintenance of both, and that this crosstalk may be disrupted in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants.

Previous work supports a model in which Shh secreted from axial mesendoderm induces *Foxa2* expression in overlying prospective floor plate; *Foxa2* in turn activates expression of *Shh* in this tissue. Shh secreted from floor plate is critical for dorsal-ventral neural patterning, such that homozygous null *Shh* mutants exhibit holoprosencephaly ([@b8]; [@b44]; [@b11]; [@b34]; [@b15]; [@b18]; [@b60]). Floor plate secretes factors that function as a molecular boundary preventing asymmetric left-sided signaling networks from diffusing across the embryonic midline. Laterality phenotypes have been associated with disruption of this function in mice ([@b35]; [@b52]). Reduced or absent expression of Shh in the anterior embryo and Foxa2 in neural groove indicated that this pathway was disrupted in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants which exhibited holoprosencephaly and laterality defects.

Surgical ablation of endodermal regions corresponding to prechordal plate in both chick and mouse models results in defective forebrain patterning, cardiac fusion, and foregut morphogenesis, supporting a role for prechordal plate in development of anterior-ventral tissues also affected in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants ([@b7]; [@b61]). Morphological abnormalities in *Foxa2^loxP/loxP^*; *Isl1-Cre* mutants also resemble what has been reported for Nodal loss-of-function mouse mutants in which defects have been attributed to deficient specification and/or formation of anterior axial mesendoderm populations, including prechordal plate ([@b42]; [@b32]; [@b56]; [@b13]; [@b31]). While Shh is required to promote survival within a subpopulation of cells comprising prechordal plate ([@b3]), *Shh* null mutants exhibit heart and foregut developmental anomalies that occurred later and are less severe than those we have observed in *Foxa2^loxP/loxP^*; *Isl1-Cre* embryos ([@b30]; [@b46]), identifying a Shh-independent Foxa2-mediated role for prechordal plate in ventral embryo morphogenesis.

We observed downregulation of a number of proteins which could, at least in part, account for observed defects in morphogenesis, proliferation, and survival of ventral endoderm in *Foxa2^+/loxP^*; *Isl1-Cre* mutants. *Isl1-Cre* mutants showed corresponding loss of Foxa2 and Gata4 expression in prospective ventral foregut endoderm cells near the site of closure. Homozygous null *Gata4* mutants exhibit ventral morphogenesis defects similar to those of *Foxa2^+/loxP^*; *Isl1-Cre* mutants, including cardia bifida ([@b26]; [@b36]). Chimeric rescue experiments demonstrated a specific requirement for Gata4 in endoderm for foregut closure ([@b23]). Previous work showing that Foxa2 directly binds to the Gata4 locus support a role for Foxa2 as a direct upstream regulator of Gata4 expression ([@b58]). Cardiac morphogenesis defects arising from ablation of Foxa2 in prechordal plate and endoderm highlight an important caveat when using Islet1Cre to investigate the role of a gene in heart development. If the gene of interest overlaps with Islet1Cre in prechordal plate and/or ventral foregut endoderm, as well as the second heart field, any observed requirement for cardiogenesis consequent to ablation with Islet1Cre cannot be attributed to a requirement within the second heart field.

Foregut endoderm of *Foxa2loxP/loxP*; *Isl1-Cre* mutants also showed reduced expression of ZO-1 and ZO-2 tight junction scaffolding components. Foxa2 has been shown to bind the *Tjp1* locus, encoding ZO-1, supporting a role for *Foxa2* as a direct upstream regulator of ZO-1 expression ([@b58]). Homozygous ZO-1 null mutants die at 11.5 dpc, due to defects in yolk sac vascular development. Homozygous null ZO-2 mutants die at 9.5 dpc with disrupted tight junctions detected by 6.5--7.5 dpc. Both ZO-1 and ZO-2 null mutants displayed elevated levels of apoptosis throughout the embryo ([@b22]; [@b62]). In a mammary epithelial cell line, tight junction formation was only eliminated when both ZO-1 and ZO-2 function was downregulated, identifying a requirement the expression of both factors for tight junction assembly. Barrier function was compromised, although adherens-mediated cell adhesion appeared intact ([@b55]; [@b54]). The foregoing suggest that diminished expression of both ZO-1 and ZO-2 observed in the foregut of *Foxa2loxP/loxP*; *Isl1-Cre* embryos is likely to disrupt tight junction assembly and identifies a role for *Foxa2* in endoderm for maintenance of the foregut epithelium tight junction network. The in vivo requirement for ZO-1 and ZO-2 to prevent apoptosis suggests that loss of these factors in *Foxa2loxP/loxP*; *Isl1-Cre* embryos may contribute to increased cell death observed in mutant foregut.

Materials and Methods {#s4}
=====================

Mouse lines, embryo collection {#s4a}
------------------------------

All mouse lines have been previously described: *Foxa2^loxP^* ([@b49]); *Isl1-Cre* ([@b64]); *Rosa^26R-lacZ^* ([@b47]). *Foxa2^loxP/loxP^* or *Foxa2^loxP/loxP^*; *Rosa^26R/26R^* females were crossed with *Foxa2^+/loxP^*; *Isl1-Cre* males to generate embryos for morphological analysis, X-gal staining, in situ hybridization, immunohistochemistry. Matings were timed with noon on day of vaginal plug detection defined as 0.5 dpc.

β-galactosidase staining, in situ hybridization, paraffin histology {#s4b}
-------------------------------------------------------------------

Embryos for whole-mount X-gal staining were collected between 7.5--10.5 dpc, fixed in 4% paraformaldehyde on ice 20--45 minutes depending on embryo size, stained according to described protocol ([@b38]).

Embryos for in situ hybridization were collected between 8.0--8.5 dpc, fixed overnight at 4°C in 4% paraformaldehyde, dehydrated through a methanol series and stored in 100% methanol at −20°C. Whole-mount in situ hybridization was performed according to described protocol ([@b38]) using the following probes: mouse *Brachyury*, *Fgf8*, *Foxa2*, *Gsc*, *Shh*. Samples were post-fixed overnight at 4°C in 4% paraformaldehyde. Post-fixed embryos processed for histology were embedded in paraffin wax and transverse sections cut at 8 µm.

Immunohistochemistry, TUNEL detection of apoptosis {#s4c}
--------------------------------------------------

Embryos for cryosectioning and immunohistochemistry were collected between 8.0--8.5 dpc, fixed in 4% paraformaldehyde on ice 20--30 minutes, washed twice in phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin, and incubated through a PBS-sucrose series (5%, 12.5%, 20%). Incubations were performed on ice for 15--60 minutes each. Embryos were embedded in 1:1 mixture of 20% sucrose and Tissue-Tek O.C.T. Embedding Compound (Sakura Finetek). Sections were cut at 10 µm unless otherwise noted.

Immunohistochemistry was performed according to described protocol ([@b38]). 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen, D3571) was used to counterstain DNA. Primary antibodies used: β-galactosidase (1:400, MP Biomedicals, 56028); Brachyury (1:400, Santa Cruz Biotechnology, 17743); Foxa2 (1:100, Santa Cruz Biotechnology, 6554); Isl1 (1:1000, Abcam, 20670); phosphohistone H3 (1:200, Upstate Biotechnology, 06-570); Shh (1:150, Santa Cruz Biotechnology, 9024). Cleaved Caspase-3 (1:100, Cell Signaling Technology, cat. 9661); E-cadherin (1:300, Sigma-Aldrich, cat. U3254); Gata4 (1:50, Santa Cruz Biotechnology, cat. 1237); Hlxb9 (1:8000, generously provided by Sam Pfaff, Salk Institute, La Jolla, CA); SOX17 (1:300, R&D Systems, cat. AF1924); ZO-1 (1:100, Invitrogen, cat. 40-2200); ZO-2 (1:200, Invitrogen, cat. 71-1400). Secondary antibodies were from the Alexafluor series (Invitrogen Molecular Probes).

Sections for TUNEL-mediated detection of apoptosis were prepared as for immunohistochemistry and stained with *In Situ* Cell Death Detection Kit, TMR red according to manufacturer\'s instructions (Roche Applied Science, 12156792910).
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